Another way is that the inhibition of L-type calcium currents by TRPA1 agonists suggests a potential role for TRPA1 channels in modulating cardiac contractility and electrical activity, which could lead to the development of selective TRPA1 modulators or channel blockers for managing cardiac arrhythmias and heart failure. The gene discussed is TRPA1; the disease is chronic obstructive pulmonary disease.